| Website | lvpcapital.com |
| Phone | 4153999880 |
| Employees | 7 |
| Founded | 2001 |
| Description | Early stage healthcare |
Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide.
| Company | Date | Round | Size | Participants |
| Femta Pharmaceuticals | 7/09 | Unattributed | $1M | 1 |
| Transcend Medical | 6/09 | Series B | $35M | 6 |
| Cell Biosciences | 4/09 | Series C | $10M | 7 |
| Pathway Medical Technologies | 3/09 | Series D | $42.5M | 5 |
| Talima Therapeutics | 5/07 | Series B | $19M | 3 |
| Pulmonx | 5/07 | Series B | $20M | 4 |
| Cell Biosciences | 2006 | Series B | $27M | 8 |